For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Search Posts
The Wall Street Journal
Drug Prices Haven’t Been Going Up
Build Back Better may be dead, but its proposed drug price controls will likely reappear: negotiating prices for high-cost drugs in Medicare and price…
City Journal
Testing Our Patience
It has only been around a little more than a month, but the Omicron variant of the SARS-CoV-2 virus that causes Covid-19 has taken…
National Review
Covid-19 Treatments and the FDA: A Sense of Urgency Might Help
As the Delta variant surges in various locales and the new Omicron variant expands around the globe, public officials are beginning to reimpose…
National Review
The Covid Mandates Should Be Ignored
the highways in South Florida, the speed limit is generally 55 mph. I don’t know why, but it doesn’t matter: Everyone blows right through…
Letters
CEI Joins NTU-Led Coalition Warns of BBB’s Impact on Drug Competition
Dear Senators and Representatives: On behalf of the undersigned organizations — taxpayer, consumer, and free market advocates from across the country — we…
City Journal
All for Show
New York City mayor Bill de Blasio will end his tenure at midnight, December 31, 2021, but he seems intent on inflicting one last…